Literature DB >> 30269285

Let us utilize breast contrast-enhanced ultrasound more.

Toshikazu Ito1.   

Abstract

Mesh：

Substances：

Year:  2018        PMID： 30269285     DOI： 10.1007/s10396-018-0904-z

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN： 1346-4523            Impact factor:   1.314


× No keyword cloud information.
  2 in total

1.  Phase II clinical study of DD-723 (perflubutane): dose-response study in patients with breast tumors.

Authors:  Yukio Miyamoto; Toshikazu Ito; Etsuo Takada; Kiyoka Omoto; Toshiko Hirai; Ryuzo Sekiguchi; Toshitaka Okuno; Shinsaku Kanazawa; Norio Nakata; Takao Igarashi
Journal:  J Med Ultrason (2001)       Date:  2012-02-03       Impact factor: 1.314

2.  Efficacy of sonazoid (perflubutane) for contrast-enhanced ultrasound in the differentiation of focal breast lesions: phase 3 multicenter clinical trial.

Authors:  Yukio Miyamoto; Toshikazu Ito; Etsuo Takada; Kiyoka Omoto; Toshiko Hirai; Fuminori Moriyasu
Journal:  AJR Am J Roentgenol       Date:  2014-04       Impact factor: 3.959
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.